SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
145In this morning's presentation during Q&A, Dr. Craig came out and said Atuck-10/5/2004
144>>Genes Dev. 2004 Mar 15;18(6):673-86. TopBP1 recruits Brg1/Brm to reprtuck-10/4/2004
143OK, so where are we with ARQ-501? My understanding is that the data presented stuck-10/3/2004
142Thanks, also !nigel bates-10/1/2004
141Thanks! (eom)scaram(o)uche-9/30/2004
140Note also the Solvay work should be getting along in the process to where it woumopgcw-9/30/2004
139Wyeth is in P1 last time I checked, but not sure of the timing except 2008 from mopgcw-9/30/2004
138listening to archived UBS.... "relevant" milestone and royalty potenscaram(o)uche-9/30/2004
137Leg: ARQL :ArQule Presents Preliminary Interim Phase 1 Data for ARQ 5 2004-09-2mopgcw-9/30/2004
136<i>These two new combination studies are due to start enrollment within thscaram(o)uche-9/29/2004
135ArQule Presents Preliminary Interim Phase 1 Data for ARQ 501 and Announces Combimopgcw-9/29/2004
134thanks for the pointer (yahoo)....... ex2.excerptamedica.com looks good.scaram(o)uche-9/28/2004
133joined.mh00034-9/26/2004
132>>understand that<< Thought you probably did. Kind of wish the seltuck-9/21/2004
131Yes, I understand that. Thanks. Morning seller..... to me, just looks likescaram(o)uche-9/21/2004
130Not sure, since we don't know exactly how ArQule has tweaked B-Lap, but the tuck-9/21/2004
129Deleted, sorry. I am challenged this morning. Cheers, Tucktuck-9/16/2004
128Rodman & Renshaw start coverage w/ $8 target and market outperform.mopgcw-9/9/2004
127Am I missing something? Is there any connection between this work and ARQL, othscaram(o)uche-9/9/2004
126Found a link to the PDF, with figures, tables, etc. in readable form: bme.case.tuck-9/8/2004
125That took some digging me thinks. Thanks for sharing..mopgcw-9/7/2004
124Remember the discussion regarding complexing ARQ-501 with a cylcodextrin to enhatuck-9/7/2004
123woensdag 29 september 2004 Poster session: Apoptosis Poster Craig, A.R. A phasscaram(o)uche-9/2/2004
122Chiang Li buys 2K shares, open market. Got a ton already. <i>That's&scaram(o)uche-8/18/2004
121AVAKIAN LAURA,Director,BUYS 1,000 ON 8/9/04 OF ARQL 2004-08-10 15:56 (New York) mopgcw-8/11/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):